There is no “best outcome” for intrahepatic cholangiocarcinoma, the prognosis of intrahepatic cholangiocarcinoma patients needs to be decided according to their own pathological condition and treatment plan, and the better outcome is to maximize the survival rate of patients through early detection and early treatment, and according to the patient’s condition, the comprehensive treatment based on surgical treatment is carried out. For intrahepatic cholangiocarcinoma patients, if they undergo surgical resection, the general 5-year survival rate is 25~35%; while the survival period of patients with advanced stage is very short, generally only 3~6 months. Intrahepatic cholangiocellular carcinoma is a kind of tumor with extremely high malignant degree among cancers, and its survival rate is related to the malignant degree of the tumor, and patients with low malignant degree have higher survival rate than those with high malignant degree. In case of intrahepatic cholangiocellular carcinoma, patients are advised to actively consult the doctor and follow the doctor’s instructions for treatment.